Počet záznamov: 1
proteíny protoonkogénové c-met
SYS d019859 LBL 00000cz--a2200000n--4500 005 20250606214513.8 008 970620|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D08.811.913.696.620.682.725.400.075 065 $a D12.776.476.568.400.075 065 $a D12.776.543.750.630.186 065 $a D12.776.543.750.750.400.100 065 $a D12.776.624.664.700.186 066 $a 01 $c 03 150 $a proteíny protoonkogénové c-met $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a c-met Proteins $2 eng 450 $w v $a Hepatocyte Growth Factor Receptor $2 eng 450 $w v $a HGF Receptor $2 eng 450 $w v $a met Proto-Oncogene Proteins $2 eng 450 $w v $a HGF receptor $2 slo 450 $w v $a receptor hepatocytového rastového faktora $2 slo 450 $w v $a proteíny c-met $2 slo 450 $w v $a proteíny protoonkogénové met $2 slo 665 $a 2006, 1998-1999 $2 eng 680 9-
$i Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. $2 eng 750 -2
$a Proto-Oncogene Proteins c-met $2 eng 980 $x M
Počet záznamov: 1